For the Media EpilepsyUSA is our full-color magazine. For The Media Departments News and Views Capitol Comments eNewsletter Check out Between Us , our full-color publication for women, appearing quarterly in our EpilepsyUSA magazine.
Partial seizures are among the most difficult to bring under control with existing treatments.
We're very pleased that physicians now have a new treatment option, with potentially fewer side effects, to help manage these seizures in children and adults. The FDA cleared oxcarbazepine for use alone in adults or in combination with other epilepsy medications in adults and children as young as four years of age in the treatment of partial seizures. The medication was developed by Novartis Pharmaceuticals Corporation. Every week the Foundation receives calls and letters from families desperate for new therapies and from others who have just been diagnosed. Even a single seizure can mean the loss of driving privileges and loss of employment, as well as other social difficulties and economic hardships.